India (CLGT:IN) from Underperform to Buy, despite reducing the price target to INR2,955.00 from the previous INR3,070.00. The upgrade comes after a notable decline in the company's stock price, which ...

(Reuters) - Procter & Gamble and Colgate-Palmolive are among the defendants in six new lawsuits targeting the sale of ...

UBS lowered the firm’s price target on Colgate-Palmolive (CL) to $104 from $112 and keeps a Buy rating on the shares. Sentiment around Consumer ...

Colgate-Palmolive (NYSE:CL – Get Free Report) will likely be posting its quarterly earnings results before the market opens ...

In a report released today, Cheria Widjaja from DBS maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a price target ...

Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $88.23 which represents a decrease of $-0.46 or -0.52% from the prior close of $88.69. The stock opened at $88.52 and touched a low of ...

Colgate-Palmolive (NYSE:CL – Free Report) had its price target trimmed by TD Cowen from $110.00 to $100.00 in a research ...

Colgate-Palmolive Co (CL) stock saw a modest uptick, ending the day at $88.56 which represents a slight increase of $0.70 or 0.80% from the prior close of $87.86. The stock opened at $87.6 and touched ...

By Jonathan Stempel (Reuters) -Procter & Gamble and Colgate-Palmolive are among the defendants in six new lawsuits targeting the sale of toothpaste and mouth rinse for young children because the ...